Effect of hydrophobic and hydrogen bonding interactions on the potency of ß‐alanine analogs of G‐protein coupled glucagon receptor inhibitors
- 23 August 2019
- journal article
- research article
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 88 (2) , 327-344
Abstract
G‐protein coupled glucagon receptors (GCGRs) play an important role in glucose homeostasis and pathophysiology of Type‐II Diabetes Mellitus (T2DM). The allosteric pocket located at the trans‐membrane domain of GCGR consists of hydrophobic (TM5) and hydrophilic (TM7) units. Hydrophobic interactions with the amino acid residues present at TM5, found to facilitate the favorable orientation of antagonist at GCGR allosteric pocket. A statistically robust and highly predictive 3D‐QSAR model was developed using 58 β‐alanine based GCGR antagonists with significant variation in structure and potency profile. The correlation coefficient (R2) and cross‐validation coefficient (Q2) of the developed model were found to be 0.9981 and 0.8253, respectively at the PLS factor of 8. The analysis of the favorable and unfavorable contribution of different structural features on the glucagon receptor antagonists was done by 3D‐QSAR contour plots. Hydrophobic and hydrogen bonding interactions are found to be main dominating non‐bonding interactions in docking studies. Presence of highest occupied molecular orbital (HOMO) in the polar part and lowest unoccupied molecular orbital (LUMO) in the hydrophobic part of antagonists leads to favorable protein‐ligand interactions. Molecular mechanics/generalized born surface area (MM/GBSA) calculations showed that van der Waals and nonpolar solvation energy terms are crucial components for thermodynamically stable binding of the inhibitors. The binding free energy of highly potent compound was found to be −63.475 kcal/mol; whereas the least active compound exhibited binding energy of −41.097 kcal/mol. Further, five 100 ns molecular dynamics simulation (MD) simulations were done to confirm the stability of the inhibitor‐receptor complex. Outcomes of the present study can serve as the basis for designing improved GCGR antagonists.Keywords
Funding Information
- Anusandhan National Research Foundation
- Department of Science and Technology, Ministry of Science and Technology (ECR/2016/000707)
This publication has 54 references indexed in Scilit:
- Computational insights into factor affecting the potency of diaryl sulfone analogs as Escherichia coli dihydropteroate synthase inhibitorsComputational Biology and Chemistry, 2019
- Virtual Screening and Experimental Testing of B1 Metallo-β-lactamase InhibitorsJournal of Chemical Information and Modeling, 2018
- Structure of the full-length glucagon class B G-protein-coupled receptorNature, 2017
- Extra-helical binding site of a glucagon receptor antagonistNature, 2016
- QSAR Modeling: Where Have You Been? Where Are You Going To?Journal of Medicinal Chemistry, 2013
- Inhibitory Mechanism of an Allosteric Antibody Targeting the Glucagon ReceptorJournal of Biological Chemistry, 2013
- A survey of small molecule glucagon receptor antagonists from recent patents (2006 – 2010)Expert Opinion on Therapeutic Patents, 2011
- Discovery and investigation of a novel class of thiophene-derived antagonists of the human glucagon receptorBioorganic & Medicinal Chemistry Letters, 2005
- Biaryl amide glucagon receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2004
- Glucagon and regulation of glucose metabolismAmerican Journal of Physiology-Endocrinology and Metabolism, 2003